Overview

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

Status:
Active, not recruiting

Trial end date:
2020-12-07

Target enrollment:

Participant gender:

Summary

The primary objective is to assess the impact of hydroxychloroquine in hospitalized patients with COVID-19 and risk factors for severe/critical disease.

Phase:

Phase 4

Details

Lead Sponsor:

WellStar Health System

Treatments:

Hydroxychloroquine